Should You Invest in U.S. Physical Therapy (USPH)?

Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. Economic slowdown, inflation, ongoing Russia-Ukraine war, and Federal Reserve actions provided uncertainty in the market. Investors reacted negatively to these issues; thus, the equity market declined considerably in the second quarter. The small-cap funds represented by the Russell 2000 Growth Index declined significantly in the quarter. Investing in small-cap companies involves more risk compared to other investments. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.

Carillon Tower Advisers discussed stocks like U.S. Physical Therapy, Inc. (NYSE:USPH) in the second quarter 2022 investor letter. Based in Houston, Texas, U.S. Physical Therapy, Inc. (NYSE:USPH) operates outpatient physical therapy clinics. On October 6, 2022, U.S. Physical Therapy, Inc. (NYSE:USPH) stock closed at $79.48 per share. One-month return of U.S. Physical Therapy, Inc. (NYSE:USPH) was 2% and its shares lost 26.07% of their value over the last 52 weeks. U.S. Physical Therapy, Inc. (NYSE:USPH) has a market capitalization of $1.034 billion.

Here is what Carillon Tower Advisers specifically said about U.S. Physical Therapy, Inc. (NYSE:USPH) in its Q2 2022 investor letter:

“U.S. Physical Therapy, Inc. (NYSE:USPH) operates in two business segments: outpatient physical therapy and industrial injury prevention services. A highly fragmented market creates an opportunity for the company to continuing consolidating operators into its business operations.”

Photographee.eu/Shutterstock.com

U.S. Physical Therapy, Inc. (NYSE:USPH) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held U.S. Physical Therapy, Inc. (NYSE:USPH) at the end of the second quarter which was 14 in the previous quarter.

We discussed U.S. Physical Therapy, Inc. (NYSE:USPH) in another article and shared Polen Capital’s views on the company. In addition, please check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

• 10 Best Fuel Cell Stocks To Invest In
• 11 Best American Dividend Stocks To Buy
• 11 Best Dividend Stocks Under $50

Disclosure: None. This article is originally published at Insider Monkey.